CA9 and breast cancer: In vivo testing using human breast cancer xenograft tumors up to 7 days post‐biomaterial implantation:No effect on tumor growth ratesNo significant changes in tumor necrosis, hypoxic cell number (CA9), proliferation (Ki67), apoptosis (caspase 3), immune cell (neutrophil, macrophage), and fibroblast infiltration or collagen deposition